laroprovstat/ezetimibe FDC
/ AstraZeneca
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 29, 2026
A Phase I, Cross-over Study Comparing the Relative Bioavailability of Laroprovstat Plus Ezetimibe Fixed Combination Drug Products Versus Their Single Therapy Products in Healthy Adults
(clinicaltrials.gov)
- P1 | N=18 | Active, not recruiting | Sponsor: AstraZeneca | Recruiting ➔ Active, not recruiting
Enrollment closed
June 17, 2026
A Phase I, Cross-over Study Comparing the Relative Bioavailability of Laroprovstat Plus Ezetimibe Fixed Combination Drug Products Versus Their Single Therapy Products in Healthy Adults
(clinicaltrials.gov)
- P1 | N=18 | Recruiting | Sponsor: AstraZeneca | Not yet recruiting ➔ Recruiting
Enrollment open
1 to 2
Of
2
Go to page
1